Dolby Laboratories (NYSE:DLB) Releases FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.190-4.340 for the period, compared to the consensus earnings per share estimate of 3.770. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q1 2026 guidance to 0.790-0.940 EPS.

Dolby Laboratories Stock Up 0.9%

Shares of DLB traded up $0.58 during trading hours on Tuesday, reaching $65.13. The company’s stock had a trading volume of 904,009 shares, compared to its average volume of 455,687. The firm has a market cap of $6.24 billion, a price-to-earnings ratio of 23.86 and a beta of 0.97. The company has a 50 day moving average of $69.07 and a two-hundred day moving average of $72.58. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on DLB shares. Tigress Financial raised their price target on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price for the company. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Finally, Barrington Research restated an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a report on Friday, September 12th. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $95.75.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction on Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the completion of the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at $7,901,110.75. The trade was a 17.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Shriram Revankar sold 7,000 shares of the company’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president owned 70,435 shares of the company’s stock, valued at $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 57,000 shares of company stock worth $4,037,690 in the last quarter. Insiders own 38.39% of the company’s stock.

Institutional Trading of Dolby Laboratories

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC lifted its holdings in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares during the last quarter. State Street Corp increased its position in Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock worth $167,906,000 after acquiring an additional 180,072 shares during the period. Goldman Sachs Group Inc. raised its stake in Dolby Laboratories by 218.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after purchasing an additional 171,288 shares during the last quarter. Millennium Management LLC lifted its stake in shares of Dolby Laboratories by 349.4% in the third quarter. Millennium Management LLC now owns 217,779 shares of the electronics maker’s stock valued at $15,761,000 after buying an additional 169,319 shares during the period. Finally, Squarepoint Ops LLC increased its position in shares of Dolby Laboratories by 37.2% during the third quarter. Squarepoint Ops LLC now owns 516,700 shares of the electronics maker’s stock valued at $37,394,000 after purchasing an additional 140,201 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.